Lupus drug combo trial aims to match treatments to immune profiles
NCT ID NCT05306873
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 25 times
Summary
This study tested two lupus medications—mycophenolate mofetil alone or with voclosporin—in 12 adults with moderate-to-severe lupus. The goal was to see if grouping patients by their immune system type could predict who responds best. The trial was stopped early, but the data may help personalize lupus treatment in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Columbia University Medical Center: Department of Medicine, Division of Rheumatology
New York, New York, 10032, United States
-
Emory University School of Medicine: Division of Rheumatology
Atlanta, Georgia, 30307, United States
-
Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases
Manhasset, New York, 11030, United States
-
Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases
Boston, Massachusetts, 02114, United States
-
Oklahoma Medical Research Foundation: Arthritis and Clinical Immunology Research Program
Oklahoma City, Oklahoma, 73104, United States
-
PennState Health Milton S. Hershey Medical Center: Division of Rheumatology
Hershey, Pennsylvania, 17033, United States
-
Piedmont Healthcare: Rheumatology Atlanta
Atlanta, Georgia, 30318, United States
-
UCLA Medical Center: Division of Rheumatology
Los Angeles, California, 90095, United States
-
University of North Carolina at Chapel Hill; Thurston Arthritis Research Center: Division of Rheumatology, Allergy, and Immunology
Chapel Hill, North Carolina, 27599, United States
-
Yale University School of Medicine: Rheumatology, Allergy & Immunology
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.